¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×Ü°æÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ i2)rDek3]T  
k]ptk^  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© \SA5@ .W  
dkLc"$( O  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© W>bhSKV%  
%* vYX0W"  
1.Co-stimulators (or co-stimulating molecules)  ZRsDn  
8/Z JkI  
2.NK-kB V0c*M>V  
v^H DR 3I  
3.Immunoglobulin superfamily T{{J' _s5L  
H.v`JNs (  
4.antigen-presenting cell (APC) UN_lK<utF  
M!;H3*  
5.death domain rV[#4,}PF  
J<>z}L{  
6.CCR and CXCR *{)[:;  
B`T|M$Ug  
7.Lectin (or mitogen) `jvIcu5c  
MS_&;2  
8.Clusters of differentiation, CD) B#B$w_z  
0A9x9l9Wd  
9.B7 family OzX\ s=  
w`c9_V  
10.Cytotoxic T lymphocyte, CTL) D 7 [n^WtL  
|\XjA4j  
11.IL-15 and IL-15 receptor (IL-15R) &z 1A-O v  
-]+ XTsL  
12.MHC restriction ;6e#W!  
i>7f9D7  
13.Affinity-chromatography yodJGGAzk  
;=5V)1~i1;  
14.Cyctosprin A, CsA 8rGW G  
N#bWMZ"  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) 7 I&7YhFI  
)>\J~{  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© \Y Cj/tG8  
I{_St8  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 LJc w->  
p27A#Uu2}  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ m{JiF-=u  
e%R+IH5i  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌص㡣 prlB9,3|C  
Q= + Frsk  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© 9x;/q7  
^W_}Gd<-#Y  
ÃâÒßѧרҵ£º FT[oM<M\Xd  
V*=cNj  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ { )'D<:T  
Jtd@8fVi  
Ïû»¯ÄÚ¿Æ£º _xl#1>G^J  
,^26.p$  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ i>ORCOOU  
,RCjfX a  
ѪҺ²¡Ñ§×¨Òµ£º }sPY+ZjV  
R>/M>*C  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
Ãâ·Ñ¿¼²©ÍøÍøÖ·ÊÇʲô? ÕýÈ·´ð°¸:freekaobo.com
°´"Ctrl+Enter"Ö±½ÓÌá½»